146 related articles for article (PubMed ID: 38704961)
1. Is it possible to treat melanoma by intercepting the CXCR4/CXCL12 pathway?
Motlak M; Mathews M; Al-Odat OS; Pandey MK
Cytokine; 2024 Jul; 179():156629. PubMed ID: 38704961
[TBL] [Abstract][Full Text] [Related]
2. The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma.
Mitchell B; Mahalingam M
Histol Histopathol; 2014 Dec; 29(12):1539-46. PubMed ID: 24879309
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
4. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.
Monteagudo C; Ramos D; Pellín-Carcelén A; Gil R; Callaghan RC; Martín JM; Alonso V; Murgui A; Navarro L; Calabuig S; López-Guerrero JA; Jordá E; Pellín A
Clin Exp Metastasis; 2012 Aug; 29(6):625-37. PubMed ID: 22526457
[TBL] [Abstract][Full Text] [Related]
5. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis.
Mortezaee K
Life Sci; 2020 May; 249():117534. PubMed ID: 32156548
[TBL] [Abstract][Full Text] [Related]
6. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
7. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility?
Mitchell B; Leone D; Feller K; Menon S; Bondzie P; Yang S; Park HY; Mahalingam M
Hum Pathol; 2014 Oct; 45(10):2094-100. PubMed ID: 25130395
[TBL] [Abstract][Full Text] [Related]
8. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer.
Yang P; Hu Y; Zhou Q
Curr Med Chem; 2020; 27(33):5543-5561. PubMed ID: 31724498
[TBL] [Abstract][Full Text] [Related]
9. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
[TBL] [Abstract][Full Text] [Related]
10. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
11. "CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression".
Franco R; Botti G; Mascolo M; Loquercio G; Liguori G; Ilardi G; Losito S; La Mura A; Calemma R; Ierano C; Bryce J; D'Alterio C; Scala S
Front Biosci (Elite Ed); 2010 Jan; 2(1):13-21. PubMed ID: 20036848
[TBL] [Abstract][Full Text] [Related]
12. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
Lin Y; Ma Q; Li L; Wang H
Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
[TBL] [Abstract][Full Text] [Related]
13. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
[TBL] [Abstract][Full Text] [Related]
14. Involvement of CXCL12/CXCR4 axis in colorectal cancer: a mini-review.
Bocchi M; de Sousa Pereira N; de Oliveira KB; Amarante MK
Mol Biol Rep; 2023 Jul; 50(7):6233-6239. PubMed ID: 37219666
[TBL] [Abstract][Full Text] [Related]
15. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
16. Activation of the CXCR4 chemokine receptor enhances biological functions associated with B16 melanoma liver metastasis.
Mendt M; Cardier JE
Melanoma Res; 2017 Aug; 27(4):300-308. PubMed ID: 28445180
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy.
Sleightholm RL; Neilsen BK; Li J; Steele MM; Singh RK; Hollingsworth MA; Oupicky D
Pharmacol Ther; 2017 Nov; 179():158-170. PubMed ID: 28549596
[TBL] [Abstract][Full Text] [Related]
19. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
Liu Y; Ren CC; Yang L; Xu YM; Chen YN
J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
[TBL] [Abstract][Full Text] [Related]
20. SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.
Dillenburg-Pilla P; Patel V; Mikelis CM; Zárate-Bladés CR; Doçi CL; Amornphimoltham P; Wang Z; Martin D; Leelahavanichkul K; Dorsam RT; Masedunskas A; Weigert R; Molinolo AA; Gutkind JS
FASEB J; 2015 Mar; 29(3):1056-68. PubMed ID: 25466898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]